WHO: COVID-19 neither manipulated nor constructed

Geneva: According to World Health Organisation(WHO), All available evidence to date suggests that the novel coronavirus has a natural animal origin and was not a manipulated or constructed virus.

The novel coronavirus was identified in early January and its genetic sequence shared publicly on January 11-12, the WHO noted. The full genetic sequence of the novel coronavirus from the early human cases and the sequences of many other viruses isolated from human cases from China and all over the world showed that the novel coronavirus has an ecological origin in bat populations, according to the world health body.

Although the intermediate animal host has not been identified, all available evidence indicated the novel coronavirus has a zoonotic source, the WHO said,.To better understand the source of the outbreak in China, a number of investigations are currently underway or planned.

Till Friday morning, the global number of coronavirus cases stood at 2,708,470, with 190,788 deaths.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid